Annual Total Expenses
$36.81 B
-$244.00 M-0.66%
December 31, 2023
Summary
- As of February 7, 2025, BMY annual total expenses is $36.81 billion, with the most recent change of -$244.00 million (-0.66%) on December 31, 2023.
- During the last 3 years, BMY annual total expenses has fallen by -$3.53 billion (-8.75%).
- BMY annual total expenses is now -8.75% below its all-time high of $40.34 billion, reached on December 31, 2020.
Performance
BMY Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$9.72 B
-$790.00 M-7.52%
September 30, 2024
Summary
- As of February 7, 2025, BMY quarterly total expenses is $9.72 billion, with the most recent change of -$790.00 million (-7.52%) on September 30, 2024.
- Over the past year, BMY quarterly total expenses has increased by +$146.00 million (+1.52%).
- BMY quarterly total expenses is now -18.37% below its all-time high of $11.91 billion, reached on December 31, 2020.
Performance
BMY Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
BMY Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -0.7% | +1.5% |
| 3 y3 years | -8.8% | +1.5% |
| 5 y5 years | +111.0% | +1.5% |
BMY Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -2.7% | at low | -7.5% | +9.2% |
| 5 y | 5-year | -8.8% | +81.9% | -18.4% | +31.6% |
| alltime | all time | -8.8% | +504.4% | -18.4% | +1165.6% |
Bristol-Myers Squibb Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $9.72 B(-7.5%) |
| Jun 2024 | - | $10.51 B(+1.5%) |
| Mar 2024 | - | $10.35 B(+8.1%) |
| Dec 2023 | $36.81 B(-0.7%) | $9.57 B(+6.3%) |
| Sep 2023 | - | $9.01 B(-3.4%) |
| Jun 2023 | - | $9.32 B(+4.7%) |
| Mar 2023 | - | $8.90 B(-8.3%) |
| Dec 2022 | $37.05 B(-2.1%) | $9.71 B(+6.5%) |
| Sep 2022 | - | $9.12 B(-1.4%) |
| Jun 2022 | - | $9.24 B(+3.0%) |
| Mar 2022 | - | $8.98 B(-6.9%) |
| Dec 2021 | $37.85 B(-6.2%) | $9.64 B(+0.4%) |
| Sep 2021 | - | $9.61 B(+2.6%) |
| Jun 2021 | - | $9.36 B(+1.3%) |
| Mar 2021 | - | $9.24 B(-22.4%) |
| Dec 2020 | $40.34 B(+99.4%) | $11.91 B(+29.5%) |
| Sep 2020 | - | $9.20 B(-0.4%) |
| Jun 2020 | - | $9.24 B(-7.6%) |
| Mar 2020 | - | $10.00 B(+35.4%) |
| Dec 2019 | $20.23 B(+16.0%) | $7.38 B(+73.8%) |
| Sep 2019 | - | $4.25 B(-3.4%) |
| Jun 2019 | - | $4.40 B(+4.6%) |
| Mar 2019 | - | $4.20 B(-4.7%) |
| Dec 2018 | $17.45 B(+0.7%) | $4.41 B(+9.4%) |
| Sep 2018 | - | $4.03 B(-22.3%) |
| Jun 2018 | - | $5.19 B(+36.1%) |
| Mar 2018 | - | $3.81 B(-22.8%) |
| Dec 2017 | $17.33 B(+15.8%) | $4.94 B(+14.8%) |
| Sep 2017 | - | $4.30 B(-3.0%) |
| Jun 2017 | - | $4.43 B(+21.4%) |
| Mar 2017 | - | $3.65 B(-15.8%) |
| Dec 2016 | $14.96 B(+0.9%) | $4.34 B(+20.4%) |
| Sep 2016 | - | $3.61 B(-3.5%) |
| Jun 2016 | - | $3.73 B(+13.9%) |
| Mar 2016 | - | $3.28 B(-25.8%) |
| Dec 2015 | $14.83 B(+4.7%) | $4.42 B(+27.9%) |
| Sep 2015 | - | $3.45 B(-14.5%) |
| Jun 2015 | - | $4.04 B(+38.4%) |
| Mar 2015 | - | $2.92 B(-31.5%) |
| Dec 2014 | $14.16 B(+5.3%) | $4.26 B(+32.3%) |
| Sep 2014 | - | $3.22 B(-10.4%) |
| Jun 2014 | - | $3.59 B(+15.9%) |
| Mar 2014 | - | $3.10 B(-13.4%) |
| Dec 2013 | $13.45 B(-1.7%) | $3.58 B(+9.1%) |
| Sep 2013 | - | $3.28 B(-4.1%) |
| Jun 2013 | - | $3.42 B(+7.7%) |
| Mar 2013 | - | $3.18 B(-13.4%) |
| Dec 2012 | $13.69 B(-6.3%) | $3.67 B(+15.4%) |
| Sep 2012 | - | $3.18 B(-7.5%) |
| Jun 2012 | - | $3.44 B(+0.8%) |
| Mar 2012 | - | $3.41 B(-12.3%) |
| Dec 2011 | $14.61 B(+7.9%) | $3.89 B(+7.8%) |
| Sep 2011 | - | $3.60 B(-2.5%) |
| Jun 2011 | - | $3.70 B(+8.1%) |
| Mar 2011 | - | $3.42 B(-8.1%) |
| Dec 2010 | $13.53 B(+1.2%) | $3.72 B(+15.4%) |
| Sep 2010 | - | $3.23 B(-0.9%) |
| Jun 2010 | - | $3.26 B(-2.2%) |
| Mar 2010 | - | $3.33 B(-2.5%) |
| Dec 2009 | $13.37 B(+5.3%) | $3.41 B(+2.0%) |
| Sep 2009 | - | $3.35 B(+1.9%) |
| Jun 2009 | - | $3.28 B(-1.3%) |
| Mar 2009 | - | $3.33 B(+333.1%) |
| Dec 2008 | $12.69 B(-19.8%) | $768.00 M(-81.0%) |
| Sep 2008 | - | $4.04 B(+3.1%) |
| Jun 2008 | - | $3.92 B(+3.0%) |
| Mar 2008 | - | $3.81 B(-25.7%) |
| Dec 2007 | $15.82 B(+6.4%) | $5.12 B(+37.5%) |
| Sep 2007 | - | $3.72 B(+2.8%) |
| Jun 2007 | - | $3.62 B(+2.5%) |
| Mar 2007 | - | $3.53 B(-1.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2006 | $14.87 B(+0.0%) | $3.57 B(-3.3%) |
| Sep 2006 | - | $3.70 B(-3.8%) |
| Jun 2006 | - | $3.84 B(+2.2%) |
| Mar 2006 | - | $3.76 B(-0.9%) |
| Dec 2005 | $14.87 B(-0.3%) | $3.79 B(+0.2%) |
| Sep 2005 | - | $3.79 B(+0.6%) |
| Jun 2005 | - | $3.77 B(+6.9%) |
| Mar 2005 | - | $3.52 B(-15.3%) |
| Dec 2004 | $14.92 B(+8.7%) | $4.16 B(+15.3%) |
| Sep 2004 | - | $3.61 B(-1.8%) |
| Jun 2004 | - | $3.67 B(+5.5%) |
| Mar 2004 | - | $3.48 B(+53.6%) |
| Dec 2003 | $13.72 B(-2.0%) | $2.27 B(-43.0%) |
| Sep 2003 | - | $3.98 B(+2.6%) |
| Jun 2003 | - | $3.88 B(+7.7%) |
| Mar 2003 | - | $3.60 B(-12.1%) |
| Dec 2002 | $14.01 B(+9.2%) | $4.09 B(+18.2%) |
| Sep 2002 | - | $3.46 B(+5.7%) |
| Jun 2002 | - | $3.27 B(+3.1%) |
| Mar 2002 | - | $3.17 B(-14.8%) |
| Dec 2001 | $12.83 B(+4.9%) | $3.73 B(+24.7%) |
| Sep 2001 | - | $2.99 B(-7.5%) |
| Jun 2001 | - | $3.23 B(+5.0%) |
| Mar 2001 | - | $3.08 B(-3.1%) |
| Dec 2000 | $12.23 B(+5.1%) | $3.18 B(+4.7%) |
| Sep 2000 | - | $3.04 B(-19.6%) |
| Jun 2000 | - | $3.78 B(+29.3%) |
| Mar 2000 | - | $2.92 B(-8.7%) |
| Dec 1999 | $11.64 B(+9.8%) | $3.20 B(+12.4%) |
| Sep 1999 | - | $2.85 B(-20.9%) |
| Jun 1999 | - | $3.60 B(+6.6%) |
| Mar 1999 | - | $3.38 B(+235.1%) |
| Dec 1998 | $10.61 B(-13.5%) | $1.01 B(-68.3%) |
| Sep 1998 | - | $3.18 B(-2.7%) |
| Jun 1998 | - | $3.27 B(+3.6%) |
| Mar 1998 | - | $3.15 B(-6.2%) |
| Dec 1997 | $12.26 B(+10.4%) | $3.36 B(+13.8%) |
| Sep 1997 | - | $2.96 B(-2.5%) |
| Jun 1997 | - | $3.03 B(+4.1%) |
| Mar 1997 | - | $2.91 B(-3.2%) |
| Dec 1996 | $11.11 B(+9.5%) | $3.01 B(+12.0%) |
| Sep 1996 | - | $2.69 B(-3.2%) |
| Jun 1996 | - | $2.77 B(+4.8%) |
| Mar 1996 | - | $2.65 B(-3.6%) |
| Dec 1995 | $10.15 B(+15.9%) | $2.75 B(+11.8%) |
| Sep 1995 | - | $2.46 B(-5.0%) |
| Jun 1995 | - | $2.58 B(+9.0%) |
| Mar 1995 | - | $2.37 B(-5.2%) |
| Dec 1994 | $8.76 B(-2.7%) | $2.50 B(+21.5%) |
| Sep 1994 | - | $2.06 B(-6.4%) |
| Jun 1994 | - | $2.20 B(+9.6%) |
| Mar 1994 | - | $2.01 B(-30.7%) |
| Dec 1993 | $9.01 B(-2.0%) | $2.90 B(+42.0%) |
| Sep 1993 | - | $2.04 B(-2.8%) |
| Jun 1993 | - | $2.10 B(+6.1%) |
| Mar 1993 | - | $1.98 B(-25.6%) |
| Dec 1992 | $9.20 B(+9.6%) | $2.66 B(+15.8%) |
| Sep 1992 | - | $2.29 B(+3.8%) |
| Jun 1992 | - | $2.21 B(+8.8%) |
| Mar 1992 | - | $2.03 B(-13.7%) |
| Dec 1991 | $8.39 B(+6.1%) | $2.35 B(+19.3%) |
| Sep 1991 | - | $1.97 B(-3.0%) |
| Jun 1991 | - | $2.04 B(+0.2%) |
| Mar 1991 | - | $2.03 B(-10.3%) |
| Dec 1990 | $7.91 B(-2.4%) | $2.26 B(+18.8%) |
| Sep 1990 | - | $1.91 B(+1.5%) |
| Jun 1990 | - | $1.88 B(+0.8%) |
| Mar 1990 | - | $1.86 B |
| Dec 1989 | $8.11 B(+19.4%) | - |
| Dec 1988 | $6.79 B(+11.4%) | - |
| Dec 1987 | $6.09 B | - |
FAQ
- What is Bristol-Myers Squibb annual total expenses?
- What is the all time high annual total expenses for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb annual total expenses year-on-year change?
- What is Bristol-Myers Squibb quarterly total expenses?
- What is the all time high quarterly total expenses for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb quarterly total expenses year-on-year change?
What is Bristol-Myers Squibb annual total expenses?
The current annual total expenses of BMY is $36.81 B
What is the all time high annual total expenses for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high annual total expenses is $40.34 B
What is Bristol-Myers Squibb annual total expenses year-on-year change?
Over the past year, BMY annual total expenses has changed by -$244.00 M (-0.66%)
What is Bristol-Myers Squibb quarterly total expenses?
The current quarterly total expenses of BMY is $9.72 B
What is the all time high quarterly total expenses for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high quarterly total expenses is $11.91 B
What is Bristol-Myers Squibb quarterly total expenses year-on-year change?
Over the past year, BMY quarterly total expenses has changed by +$146.00 M (+1.52%)